Accord Healthcare took home four awards including Company of the Year at the Global Generics and Biosimilars Awards, held in Frankfurt, Germany on November 2nd.
The company also won the Biosimilar Initiative of the Year, Value Added Medicine Initiative of the Year and Regulatory Achievement of the Year.
Speaking after the success, Paul Tredwell, EVP, EMENA says: “Year after year we are continuously recognised at these prestigious awards and that a is testament to our people, our culture and our drive to make it better and the innovations we invest in.
“To be named Company of the Year, take the award for Biosimilar Initiative of the Year, Value Added Medicine Initiative of the Year, and Regulatory Achievement of the Year is a real accomplishment for everyone here at Accord and a real achievement to be awarded four in a highly competitive ceremony.”
